[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20033854D0 - N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse - Google Patents

N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse

Info

Publication number
NO20033854D0
NO20033854D0 NO20033854A NO20033854A NO20033854D0 NO 20033854 D0 NO20033854 D0 NO 20033854D0 NO 20033854 A NO20033854 A NO 20033854A NO 20033854 A NO20033854 A NO 20033854A NO 20033854 D0 NO20033854 D0 NO 20033854D0
Authority
NO
Norway
Prior art keywords
norbuprenorphine
enyl
methods
Prior art date
Application number
NO20033854A
Other languages
English (en)
Other versions
NO20033854L (no
Inventor
Bruce E Reidenberg
Donna-Donigi Gale
Vinayak J Srinivasan
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of NO20033854D0 publication Critical patent/NO20033854D0/no
Publication of NO20033854L publication Critical patent/NO20033854L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20033854A 2001-03-02 2003-09-01 N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse NO20033854L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27281901P 2001-03-02 2001-03-02
PCT/US2002/006766 WO2002070524A2 (en) 2001-03-02 2002-03-04 N-but-3-enyl norbuprenorphine and its use as analgesic

Publications (2)

Publication Number Publication Date
NO20033854D0 true NO20033854D0 (no) 2003-09-01
NO20033854L NO20033854L (no) 2003-10-28

Family

ID=23041438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033854A NO20033854L (no) 2001-03-02 2003-09-01 N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse

Country Status (14)

Country Link
US (2) US7125884B2 (no)
EP (1) EP1368356A2 (no)
JP (1) JP2004538256A (no)
KR (1) KR20030088445A (no)
CN (1) CN1507448A (no)
BR (1) BR0207978A (no)
CA (1) CA2439859A1 (no)
IL (1) IL157662A0 (no)
MX (1) MXPA03007885A (no)
NO (1) NO20033854L (no)
NZ (1) NZ528241A (no)
RU (1) RU2003129531A (no)
WO (1) WO2002070524A2 (no)
ZA (1) ZA200307337B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10340428B4 (de) * 2003-09-02 2015-02-12 Acino Ag Opioides Analgetikum enthaltende transdermale Formulierung
FR2875406B1 (fr) * 2004-09-21 2007-01-05 Danisco Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
PL2326651T3 (pl) 2008-07-30 2014-05-30 Purdue Pharma Lp Analogi buprenorfiny
SI2619212T1 (sl) 2010-09-21 2016-04-29 Purdue Pharma L.P. Analogi buprenorfina kot agonisti in/ali antagonisti opioidnih receptorjev
WO2013084060A1 (en) * 2011-12-08 2013-06-13 Purdue Pharma L.P. Quaternized buprenorphine analogs
RU2506265C1 (ru) * 2012-08-21 2014-02-10 Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) Фторсодержащие производные тевинола и орвинола и способы их получения (варианты)
RU2503678C1 (ru) * 2012-08-21 2014-01-10 Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) 7α-(1-ГИДРОКСИ-2,2,2-ТРИФТОРЭТИЛ)-17-МЕТИЛ-3,6-ДИМЕТОКСИ-4,5α-ЭПОКСИ-6α,14αЭТЕНОИЗОМОРФИНАН И СПОСОБ ЕГО ПОЛУЧЕНИЯ
US10138207B2 (en) 2012-11-09 2018-11-27 Purdue Pharma, L.P. Benzomorphan analogs and the use thereof
EP2931729B1 (en) 2012-12-07 2019-02-06 Purdue Pharma LP Buprenorphine analogs as opiod receptor modulators
TW201441199A (zh) * 2012-12-28 2014-11-01 Purdue Pharma Lp 經取代之嗎啡喃類及其用途
CA2900023A1 (en) 2013-01-31 2014-08-07 Purdue Pharma L.P. Benzomorphan analogs and the use thereof
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
US9994571B2 (en) 2013-12-26 2018-06-12 Purdue Pharma L.P. 10-substituted morphinan hydantoins
US9862726B2 (en) 2013-12-26 2018-01-09 Purdue Pharma L.P. Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
EP3087078B1 (en) 2013-12-26 2019-05-15 Purdue Pharma LP 7-beta-alkyl analogs of orvinols
JP6353543B2 (ja) 2013-12-26 2018-07-04 パーデュー、ファーマ、リミテッド、パートナーシップ 環縮小モルフィナン及びその使用
WO2015099863A1 (en) 2013-12-27 2015-07-02 Purdue Pharma L.P. 6-substituted and 7-substituted morphinan analogs and the use thereof
CA2950567A1 (en) 2014-05-27 2015-12-03 Purdue Pharma L.P. Spirocyclic morphinans and use thereof
CA2951697A1 (en) 2014-06-13 2015-12-17 Purdue Pharma L.P. Azamophinan derivatives and use thereof
MA41125A (fr) 2014-12-05 2017-10-10 Purdue Pharma Lp Dérivés de 6.7-cyclomorphinane et leur utilisation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
US3285914A (en) * 1964-06-11 1966-11-15 Smith Kline French Lab 3-n-substituted derivatives of oripavine and thebaine
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
CA2319627A1 (en) * 1998-01-29 1999-08-05 Polychip Pharmaceuticals Pty. Ltd. Therapeutic compounds

Also Published As

Publication number Publication date
WO2002070524A2 (en) 2002-09-12
NZ528241A (en) 2004-08-27
CN1507448A (zh) 2004-06-23
BR0207978A (pt) 2004-03-02
CA2439859A1 (en) 2002-09-12
JP2004538256A (ja) 2004-12-24
US20040087605A1 (en) 2004-05-06
NO20033854L (no) 2003-10-28
US20050192308A1 (en) 2005-09-01
MXPA03007885A (es) 2004-05-24
KR20030088445A (ko) 2003-11-19
ZA200307337B (en) 2004-12-20
US7125884B2 (en) 2006-10-24
WO2002070524A3 (en) 2002-10-17
RU2003129531A (ru) 2005-04-10
EP1368356A2 (en) 2003-12-10
IL157662A0 (en) 2004-03-28

Similar Documents

Publication Publication Date Title
NO20033387D0 (no) Modifiserte antistoffer og fremgangsmåter for anvendelse
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20041975D0 (no) Bicyklisk oksopyridin og oksopyrimidinderivater
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20011964L (no) Brönnbehandlingsfluider og fremgangsmåter for anvendelse derav
NO20042147L (no) Heterocykliske forbindelser og fremgangsmater for anvendelse derav
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
DK1539224T3 (da) Antimikrobielt præparat og fremgangsmåde til anvendelse
NO20032668D0 (no) Gyraseinhibitorer og anvendelser derav
NO20035704D0 (no) Fraktureringsfluider og fremgangsmåte og anvendelse derav
NO20042229L (no) Type 4-fosfodiestemseinhibitorer og anvendelse derav
DK1251848T3 (da) Gyraseinhibitorer og anvendelse deraf
IS7725A (is) Imidazólópyridín og aðferðir við framleiðslu og notkun þeirra
DK1601744T3 (da) Forgasningsapparat og fremgangsmåde
NO20011026D0 (no) Matvare og fremgangsmÕte for fremstilling derav
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
IS2867B (is) Neublastín sem tengt er fjölliðu og aðferðir við notkun þess
NO20030843L (no) Anordning og fremgangsmåte for kultivering
NO20023843D0 (no) Skumanordning og fremgangsmåte
DK1406895T3 (da) Lactonformuleringer og fremgangsmåde til anvendelse deraf
DK1441746T3 (da) Sammens tning og fremgangsmode
NO20032821D0 (no) Sea-trosy og beslektede fremgangsmåter
NO20042126L (no) Syntese av 2-aralkoksyadenosiner og 2-alkoksyadenosiner
DE60143766D1 (de) Dübel und verwendungsverfahren dafür

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application